MONROVIA, Calif., July 28, 2014 /PRNewswire/ -- STAAR Surgical
Company (NASDAQ: STAA) a leading developer, manufacturer and
marketer of implantable lenses and delivery systems for the eye has
rescheduled the release of its second quarter results and
conference call with investors to July 31,
2014 at 5:00 p.m. EDT from
July 30, 2014. The Company
rescheduled the release date and conference call to enable senior
management attendance at the funeral services for Hideo Watanabe, President of STAAR Japan, who
passed away of Sunday, July 27,
2014. Mr. Watanabe had been President of STAAR Japan since
2011.
"Hideo led our Japanese operations for the past three years and
was a contributor to STAAR's growing success in Japan and China. Hideo led the efforts
on the manufacturing transfer of IOLs from Japan and also the efforts to increase sales
results on IOLs in Japan. The entire STAAR team and Board of
Directors mourn his passing and express our deepest condolences to
his wife and three sons," said Barry
Caldwell, President & CEO of STAAR. "While we
regret the inconvenience caused to our shareholders with the one
day delay in our reporting results, I feel it was important for me
to personally attend the funeral services for a friend of the
Company, the ophthalmic industry and the employees of STAAR
Surgical throughout the world."
STAAR will host its conference call and webcast on
Thursday, July 31 at
5:00 p.m. Eastern / 2:00 p.m. Pacific to
discuss these results and recent corporate developments. The
dial-in number for the conference call is 866-515-2907 for domestic
participants and 617-399-5121 for international participants, both
using the passcode 24164533. The Company will also be using
slides to illustrate its second quarter results and operational
progress. The slides and live webcast with accompanying slides can
be accessed from the investor relations section of the STAAR
website at www.staar.com.
A taped replay of the conference call will also be available
beginning approximately one hour after the call's conclusion for
seven days. This replay can be accessed by dialing
888-286-8010 for domestic callers and 617-801-6888 for
international callers, both using passcode 54025734. An
archived video webcast will also be available at www.staar.com.
About STAAR Surgical
STAAR, which has been
dedicated solely to ophthalmic surgery for over 25 years, designs,
develops, manufactures and markets implantable lenses for the eye
and delivery systems there for. All of these lenses are foldable,
which permits the surgeon to insert them through a small incision.
STAAR's lens used in refractive surgery as an alternative to LASIK
is called an Implantable Collamer® Lens or "ICL." A lens used to
replace the natural lens after cataract surgery is called an
intraocular lens or "IOL." More than 450,000 Visian ICLs have been
implanted to date; to learn more about the ICL go to:
www.visianinfo.com. STAAR has approximately 335 full time employees
and markets lenses in over 60 countries. Headquartered in
Monrovia, CA, it manufactures in
Aliso Viejo, CA and Monrovia, CA. For more information, please
visit the Company's website at www.staar.com.
CONTACT:
|
Investors
|
Media
|
|
EVC Group
|
EVC Group
|
|
Doug Sherk,
415-652-9100
|
Nicole Kruse,
212-850-6025
|
SOURCE STAAR Surgical